Trade Diaceutics Plc - DXRX
Diaceutics PLC (LSE: DXRX) is a data analytics and diagnostics commercialisation company serving the precision medicine sector. It provides pharma companies with insights and infrastructure to optimise test adoption and patient identification in global drug launches. The company’s DXRX platform integrates real-world data and lab networks to streamline diagnostic pathways, supporting faster, more effective personalised therapies. With a focus on improving patient outcomes, Diaceutics operates at the forefront of precision healthcare.Latest shares articles

Cellnex stock forecast: BlackRock raises stake to 6.398%
Cellnex Telecom is a European telecom-infrastructure company listed in Madrid. In September, BlackRock raised its stake to 6.398% as Cellnex continued its share-buyback programme. Explore third-party CNLX price targets Past performance is not a reliable indicator of future results.
an hour ago

Siemens stock forecast: VinSpeed high-speed rail contract
Siemens is a German industrial group with businesses across automation, infrastructure and mobility. On 22 September 2026, Siemens Mobility signed a high-speed rail contract with VinSpeed. Explore third-party SIE price targets. Past performance is not a reliable indicator of future results.
3 hours ago

DeFi Technologies stock forecast: Valour hedge fund launch
DeFi Technologies' subsidiary Valour launched its first hedge fund on 21 September 2026, expanding the business beyond exchange-traded products. Explore third-party DEFT price targets and technical analysis. Past performance is not a reliable indicator of future results.
5 hours ago

Buzzi stock forecast: H1 EBITDA and margin pressure
Buzzi is an Italian building-materials group listed in Milan, with recent trading shaped by a September share-price decline and a new investor presentation. Explore third-party BZU price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:07, 25 September 2026
Related News